◆英語タイトル:Berg LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10580
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns on diseases. Its pipeline products include BPM 31510 and BPM 31543. Berg’s platform identifies therapies and biomarkers by applying algorithm and probability-based artificial intelligence to analyze large numbers of patient’s genotypic, phenotypic, and other characteristics. The company carries out research and development of diagnostics, theranostics and patient therapeutics in the areas of oncology, endocrinology and neurology. Its analytics engine enables health plans, EHR vendors, providers, and clinical decision support organizations to plan, implement and measure interventions. Berg is headquartered in Framingham, Massachusetts, the US.
Berg LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Berg LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson’s Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson’s Institute 19
Berg LLC – Key Competitors 20
Berg LLC – Key Employees 21
Berg LLC – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Feb 07, 2017: BERG Announces Appointment of Titus Plattel as Chief Operating Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Berg LLC, Pharmaceuticals & Healthcare, Key Facts 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson's Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson's Institute 19
Berg LLC, Key Competitors 20
Berg LLC, Key Employees 21
List of Figures
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9